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Monitoringexposure toalkylatingagentsmaybeachievedbyquantitatively determiningtheadductlevelsformedwith
nucleic acidsand/orproteins. Oneofthemostsignificant resultsarisingfromtheapplicationofthisapproach hasbeen
thediscovery incontrol populations of"background" levelsofalkylated nudeic acidbasesoralkylated proteins, inpar-
ticular hemoglobin (Hb). InthecaseofHb, awidevarietyofsuchadductshavebeendetected and quantitated by mass
spectrometric techniques, withmethylated,2-carboxyethylated, and2-hydroxyethylated modifications beingmostabun-
dant. Althoughthesourceofthesealkylation products isunknown, bothendogenousandexogenoussourcesmay bepro-
posed. We haverecentlyconfirmed the presenceoftheN-terminal hydroxyethylvaline adduct incontrol human Hb us-
ing tandem mass spectrometry (MS-MS) and have now established background levels using GC-MS in more than 70
samples. Smoking raisesthelevelsoftheadduct upto 10-foldandoccupationalexposuretoethyleneoxideupto300-fold.
Background levelsofalkylated nucleic acidsmaybestudiedbyanalysisofN7-alkylatedguanine orN3-alkylatedadenine,
which are excised from nucleic acidsaftertheir formation and areexcreted in urine. Although the presenceofsomeof
theseurinary constituents may beaccountedforbytheirnatural occurrence inRNAordiet,theendogenous orexogenous
sourceofothersisunknown.QuantitativemethodsusingMS-MShavenowbeendevelopedforfiveoftheobservedurinary
alkylguanines [N7-methyl-, N2-methyl-, N2-dimethyl-, N7-(2-hydroxyethyl)-, andN2-ethylguanine]. A GC-MS method
has also been developed to measure urinary thymine glycol as a possiblemonitorofoxidative DNA damage.
Introduction
A variety ofanalytical approaches have been and are being
developed to detect carcinogen adducts in DNA as a means of
monitoring the biologically effective dose of the carcinogen
received by an individual. These detection methods include 32P-
postlabeling, fluorescence spectroscopy, radio- and enzyme-
linked immunoassay, andMSprocedures. Allofthesemethods
are extremely sensitive, the highest detection limit being with
32P-postlabeling which canshow the presenceofonecarcinogen-
modified nucleic acid base per 10'-101 bases. Mass spec-
trometry procedures, although not as sensitive aspostlabeling,
confertheadditional advantage thatthey givechemical structural
information on the adduct. Mass spectrometry has also been
widely used for the detection ofcarcinogen adducts with pro-
teins, and in particular with hemoglobin (Hb). The ready
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availabilityofHb, coupledwithitslonglifetime, makes itacon-
venientmolecule formonitoring acute and chronic carcinogen
exposure.
OneofthemostsignificantfindingsinthestudiesofDNAand
Hbcarcinogenadductshasbeenthedetectionof"background"
levels of adducts in supposedly unexposed populations. The
sourceofthesebackgroundadductsisingeneralunknown, and
couldbeduetooneormoreofthefollowing: a) anendogenous
metabolicpathway, b) anendogenouscatabolicpathwaythatpro-
ducestheadductasadegradationproductofanothermolecule,
c) exogenous exposure to the carcinogen through a route or
mechanism that was not recognized, d) exposure to the car-
cinogenproducedby anendogenousmechanism, e) intakeofthe
adductthroughthediet, or]) contaminationofreagents/labora-
tory environment with thecarcinogen.
Inthispaperthebackgroundadductsthathavebeendetectedby
MS are reviewed, and our current approaches for increasing
specificityfortheirdetectionareoutlined. Mostoftheadductsto
be discussed are those formed by the reaction between elec-
trophilic carcinogens and nucleophilic residues within the
macromolecule.FARMERETAL.
Hemoglobin Adducts
Methyl
S-Methylcysteine (Fig. 1) was the firstadduct shown to have
background levels (1). It was detected by chemical ionization
GC-MSanalysisofHbacidhydrolysates. Itsconcentration inHb
is species dependent, being highest in avian species (e.g., 296
nmole/gglobin inchickens). Thelowestlevel recordedisinthe
hamster(5.6nmole/gglobin). Humanscontainaboutthreetimes
theadductpresent inhamsters (Table 1). Although theidentifica-
tionofS-methylcysteine iswithoutdoubt, its sourceisuncertain.
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Artifactual production during the work-up procedure is con-
ceivable (2), althoughthishypothesishasnotbeensupportedby
our work (3). S-Methylcysteine sulfoxide, which may be a
precursor ofS-methylcysteine, is a natural constituent offood
(4), andthefreeaminoacidhasalsobeendetectedinplants(5).
Incorporation ofthemethylated aminoacid in thebiosynthesis
ofHbhasbeenproposedby Tornqvistetal. (6) asacontributor
to the background levels of S-methylcysteine. Endogenous
pathways involving methylation by S-adenosylmethionine are
also feasible.
Humancontrol HbalsocontainsN'-methylhistidine (detected
byGC-MSoraminoacidanalysis) (Fig. 1; Table 1) (6). This is
alsoaconstituentoffoodandcouldbemisincorporated intoHb.
Additionally, itis aconstituentofmuscleproteins andexists in
human urine (7). The N-terminal valine in Hb was shown by
Tornqvistetal. (6) tobepartially methylated (Fig. 1; Table 1).
Themisincorporation ofN-methylvaline inHbbiosynthesis was
not considered to be likely, and endogenous methylation by S-
adenosylmethionine orbyareactionwithformaldehydewaspro-
posed as the source ofHb N-methylvaline.
ThelevelsofbackgroundmethylatedadductsinHbpreventthe
use of these adducts as monitors of low levels of exogenous
methylating agent exposure. Thus, using the rat as amodel, to
generate a 50% increase over background levels of S-meth-
ylcysteinewouldrequiretheanimaltobeadministeredabout20
mg nitrosodimethylamine/kg body weight (1). Exposure to
stableisotope-labeled methylatingagentshas, however, satisfac-
torilybeenmonitored (astherewillnaturallybenobackground
adducts for these) through determinations of Hb S-
methylcysteine (8) orcarboxylic acid methyl esters (9).
CH2CH2COOH
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FIGURE 1. Structures of some alkylated amino acids isolated from control
hemoglobin.
Table 1. Background levels ofmodified aminoacids in humanhemoglobin.
Amino acid
S-Methylcysteine
N'-Methylhistidine
NT-Methylvaline
S-(2-Carboxyethyl)cysteine
N-(2-Hydroxyethyl)histidine
S-(2-Hydroxyethyl)cysteine
N-(2-Hydroxyethyl)valine
Sulfinamides
4-Aminobiphenyl
Aniline
o-Toluidine
m-Toluidine
p-Toluidine
2-Aminonaphthalene
Adduct level,
nmole/gglobin Reference
16.4 Bailey et al. (1)
12-42 T6rnqvist et al. (6)
0.5 Tornqvist et al. (6)
8.5 Bailey et al. (19)
1.6 Van Sittert et al. (10)
1-3 Kautiainen et al. (16)
0.05 Bailey et al. (13)
pmole/g Hb
0.18 Bryant et al. (22),
Perera et al. (23)
41 Stilwell et al. (24)
0.32 Stilwell et al. (24)
6.4 Stilwell et al. (24)
0.65 Stilwell et al. (24)
0.04 Stilwell et al. (24)
2-Hydroxyethyl
N'-(2-Hydroxyethyl)histidine (Fig. 1) inHbmaybedetermin-
edby GC-MS followingtotal acidichydrolysis oftheglobin (6
N HCI, 110' in vacuo), ion exchange chromatography, and
derivatization. Backgroundlevelsof1.59 + 0.18nmole/gglobin
werefoundinman(10)and 1.3 -2.8nmole/gglobininrats (11).
The analytical procedure involves time-consuming chromato-
graphic steps and detection limits are only about 0.5 nmole/g
globin.
HydroxyethylationoftheNH2-groupoftheN-terminalvaline
has alsobeendemonstrated incontrolpopulations. Thisadduct
(Fig. 1) may be determined following a modified Edman
degradation (usingpentafluorophenyl isothiocyanate) toliberate
itfromtheproteinasathiohydantoin(12). Theproductisquan-
titatedbyGC-MSusingglobinmodifiedbyd4-ethyleneoxideas
internalstandard. Theprocedureusedinourlaboratory involves
conversion of the thiohydantoin to its trimethylsilyl (TMS)
derivative, followedbyanalysisbyelectronimpact(El) GC-MS
(13). The detection limit is 10 pmole adduct/g globin. In our
original study, background levels of 52.1 + 20.5 pmole N-
(2-hydroxyethyl)valine (HEV)/g globin were found in control
subjects (n = 23). Wehavesubsequently analyzedafurther47
controls. HEVwasfoundineveryperson(range 13-126pmole/g
globin), with amean value of46.4 ± 26.1 pmole/gglobin. No
correlations have been found with age or sex.
Therelativesignificance oftheHEVbackground levels may
bejudgedbycomparisonwithwhatwehaveobservedinexposed
individuals, e.g., patients receiving a single dose ofthe anti-
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FIGURE 2. Multiple reaction monitoring GC-MS of the trimethylsilyl de-
rivative ofN-(2-hydroxyethyl)valine pentafluorophenylthiohydantoin (m/z
440 to 350) andofits tetradeuterated analog used as internal standard (m/z
444to354). The retentiontimeofthisderivative is6.2 min. Thesamplewas
obtained from control human globin.
cancer drug 1-[4-amino-2-methyl(pyrimidin-5-yl)methyl]-3-(
2-chloroethyl)-3-nitrosourea (ACNU): 330pmole/g globin (14);
smokers of 10cigarettes/day: 170pmole/gglobin (13); ethylene
oxide workers: up to 16.1 nmole/g globin (15).
Further validation ofthe chemical nature ofthe background
adducthasbeenachievedbyusing MS-MS/tandem mass spec-
trometry fordetectingtheproductas itelutedfromtheGC. The
MS-MS instrument used to determine this was a VG-70 SEQ,
which has theconfiguration:electrostatic analyzer, magnet,Rf
only quadrupole collision cell, quadrupole analyzer. The
molecular ionoftheTMSderivativeofHEVpentafluorophenyl-
thiohydantoin (m/z 440) fragments inthecollision cell toyield
afragment (ordaughter) ion(m/z350), whichisdetectedbythe
quadrupole analyzer. Monitoring this fragmentation (multiple
reactionmonitoring; MRM)yieldsamuch more selectivedetec-
tion ofthecompound incomparison to single MSselective ion
recording (SIR) ofm/z 440. Contaminants that aredetected on
aSIRtracebecausetheyyield(likeHEV) an ion atm/z440 are
virtually absent from an MRM trace. Quantitation may be
achieved in the MS-MS analysis by rapid switching from the
fragmentation440to350totheanalogous fragmentationderived
fromthetetradeuterated internal standard 444to354, anddeter-
mination of peak area ratios. We have achieved satisfactory
calibration linesforsuchananalysisandhaveappliedittoglobin
samples from apopulation exposed occupationally to ethylene
oxideandtocontrols(unpublishedobservations). Figure2 shows
the MRM analysis for HEV in control globin, which clearly
shows detectable levels ofendogenous HEV.
NumerousspeculationsmaybemadeastothesourceofHEV.
Itis notincorporatedintoHb(16), andtherefore adietary source
seemsunlikely. It seemslikelythatendogenous orexogenous ex-
posuretoahydroxyethylating agentisinvolved. Pbssible sources
are environmental ethylene or ethylene oxide (exhaust fumes,
cigarettesmoke), orendogenouslyproducedethylene. Evidence
hasbeenobtainedthatlipidperoxidation andmetabolismofin-
testinal bacteria maybothcontributetoHEVlevelsinHb(17,18).
2-Carboxyethyl
Thediscovery ofthe presence ofS-(2-carboxyethyl)cysteine
(Fig. 1) inhydrolyzedglobinstemmedfromaninvestigationinto
thebindingofacrylamidetoHb(19). Acrylamidehasthehighest
binding index known (8.6nmoleadduct/g globinper ,umole/kg
body weightdose [rat]) for reaction with Hb and is believed to
produce S-(3-amino-3-oxopropyl)cysteine. During the acid
hydrolysis oftheprotein foradduct isolation, the carboxamido
grouphydrolyzestotheacid, yieldingS-(2-carboxyethyl)cysteine
(CEC), the determination of which was used for GC-MS
monitoringofacrylamideexposure. Veryhighbackgroundlevels
of CEC were found in hydrolyzed Hb of rats (21.4 nmole/g
globin) andman(Table 1). Itisconceivablethattheselevelsare
caused by exogenous exposure to acrylamide, which is widely
used in the production ofpolyacrylamides. In the rat, the dose
(IP) ofacrylamide needed to generate the background may be
estimated as 0.3 mg/kg (19). CEC is a natural constituent of
human urine (20), and endogenous pathways for its formation
from components of the glycolytic pathway may be feasible.
However, itshouldbemadeclearthatthechemical natureofthe
modified cysteine in intact Hb has not yetbeen determined.
Phenylhydroxyethyl
In view ofour successatdetecting hydroxyethyl adducts, we
have recently devised methods for monitoring phenylhydroxy-
ethyladductsthatwouldbederivedfromexposureto styreneox-
ide (21).
An analytical method for the N-terminal valine adduct has
been developed using the modified Edman degradation (see
"2-Hydroxyethyl"). The resulting pentafluorophenylthio-
hydantoin is purified by Sep-Pak solid-phase chromatography,
convertedtotheacetyl orTMSderivative, anddetectedby GC-
MS SIR. Quantitation is achieved using an internal standard
preparedby reactingd8-styreneoxidein vitrowithHb. Thelower
limitofdetectionofthe assay is 10 pmole adduct/g globin, and
theyieldofthiohydantoinproduced intheprocedure(determined
by radiochemical means) accounted for 5.2% of total globin
alkylation in vitro by styrene oxide.
Styreneoxidealso reactswithcarboxylicacidresidues inHb,
yieldingphenylhydroxyethyl esters. Mildbasic hydrolysis ofthe
globin cleaves these esters, yielding 1-phenyl-1,2-ethanediol
(styrene glycol). The yield ofthis product extracted into ethyl
acetate accounted for 15% oftotal globin alkylation in vitro by
styreneoxide. AGC-MSSIRmethodtodetectstyreneglycol in
globin hydrolysates, with a limit of detection of 20 pmole/g
globin, has been developed to yield a second estimate of the
bounddoseofstyreneoxide. Theliberatedstyreneglycol iscon-
verted to its TMS derivative and quantitated by SIR using
d8-styrene glycol (derived from globin labeled in vitro with
d8-styreneoxide) as internal standard. Rigorous solventpurifica-
tion was required to remove contaminants. Analysis ofglobin
samples (n = 10) from unexposed humans did not reveal the
presenceofbackground levelsofstyreneoxideadducts, withthe
above-mentioned limits ofdetection.
AromaticAmines
Aromaticamineadductswith Hb maybedeterminedbyacidic
oralkalinehydrolysis ofthelabilecysteinesulfinamideadducts,
followed by extraction of the free amine, derivatization, and
GC-MS SIR. Studies on4-aminobiphenyl (4-ABP) adductsby
Bryant et al. (22) showed the presence of species-dependent
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backgroundlevels. Humanbackground levelswere28pg/g Hb,
whereas ratshad500-3000pg/gHb, andmonkeysandfishhad
lessthanthedetection limitof5-10pg/g Hb. Thebackgroundin
humans wasalsoreportedbyPereraetal. [32.2 + SD 12.3pg/g
Hb (23)]. The source ofthis background level is unlikely to be
endogenous, and it is suspected to be from passive cigarette
smoking, diet, orairpollution. Analogousanalysesforadducts
fromotheraromatic amines (Table 1) also showedbackground
levels, again ofan unknown source (24).
Wehaverecentlydevelopedmethods fordetermining adducts
to Hb of 4,4'-methylenedianiline (MDA) (25) and 4,4'-
methylene-bis(2-chloroaniline) (MOCA) (26). These both in-
volvebasichydrolysisofHb(whichliberates40% ofthebound
dosefromitssulfinamideadduct), solventextraction, conversion
to the pentafluoropropionyl derivative, and EI GC-MS SIR,
using adeuterated internal standard. Thelimitofdetection is 10
pmole/g HbforMDAand20pmole/g HbforMOCA. Inthecase
ofMDA, asecondadduct, containingtheacetylatedamine, was
alsodetectedandsimilarlydetermined. Analysis ofratsamples
H NJX
NH2 --N N
N-7-methylguanine
O ClH2CH20H
HN N
NH2- euN N
N-7-(2-hydroxyethyl)guanine
NH2
N, N
IH3
N-3-methyladenine
Thymine glycol
FIGURE 3. Structures ofsomemodified nucleic acidbasesisolatedfromurine.
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showednodetectablebackground ofMDA, N-acetyl MDA, or
MOCA. AnalyseshavebeenconductedonMDAHbsamplesob-
tainfromhumans. Adductswerenotdetected in 10control sub-
jects, butwerefoundin 12workerswithoccupationalexposure
toMDA(upto55.3pmoleMDAadduct/gglobinand91.8pmole
N-acetyl MDA adduct/g globin).
Nucleic Acid Adducts
Urinary AlkylatedPurines
Modification ofnucleicacidsbyalkylatingcarcinogens results
in the formation ofmany adducts, including N7-alkylguanines
andN3-alkyladenines. Bothofthesebasesarerapidlyremoved
fromthenucleicacidandexcretedintheurine. Theirmeasure-
ment represents an approach for screening an individual's ex-
posure to alkylating carcinogens over the previous 24 hr.
However, background levels, particularly of low molecular
weight alkyl groups do exist.
N7-Methylguanine (Fig. 3) is abundant in urine (about 6.5
mg/24hr) (27). Ourmethod forthispurine's determination in-
volvesSep-Pakcolumnchromatography, followedbyconversion
to thepentafluorobenzyl N-heptafluorobutyryl derivative, and
EI GC-MS SIR. Because of the high background levels of
N7-methylguanine, this method is unsuitable for monitoring
human methylating agent exposure except in cases where the
compoundisstable-isotopelabeled, forwhichtherewouldbeno
background(28). ThesourceofN-7-methylguanine istRNA, in
which it is a minor base. We have also monitored urinary
N3-methyladenine (Fig. 3) by GC-MS SIR of its tert-butyl-
dimethylsilyl derivative (TBDMS) (29), and foundthis also to
be present inhuman urine, although atmuch lower levels than
N7-methylguanine (4.5-16.1 pg/24 hr). The source of N3-
methyladeninewasshowntobelargelyduetothedietby Prevost
etal. (30).
We have now used MS-MS to explore the presence ofother
alkylguaninesinurine. AliquotsofurinewereappliedtoaC-18
Sep-Pak column, which was washed with water, and the
alkylguaninefractionwaselutedwithaqueousmethanol. Parent
ionscanningofm/z 151 (guanine+) (31) showedthepresenceof
/d3TG
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FIGURE 4. Electron impact daughter ion spectra ofm/z 195 (collision energy
- 30eV, air in the gas cell 10-8mbar). (a) Human urineeluted fromSep-
Pakcartridge with 70% aqueous methanol. Ionsmarked (0) correspond to
ionsobserved in a solvent blanktakenthrough the method orcontaminants
inthe urine. (b) Sameurinesamplespiked withN7-(2-hydroxyethyl)guanine.
6.5 7.0 7.5
min.
FIGURE 5. Selective ion recording GC-MS of the tert-butyldimethylsilyl
derivativeofthymineglycol(TG)(m/z331)andofitstrideuteratedanalogused
as internal standard(m/z 334). Theretentiontimeofthederivative is7.1 min.
The sample was obtained from control human urine.
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several ions, notably oneatm/z 179andoneatm/z 195, isobaric
with an ethylated (or dimethylated) and a hydroxyethylated
guanine, respectively.
An El daughter spectrum ofm/z 179 tentatively revealed the
presenceofboth N2-dimethylguanine andanethylated guanine.
By performing hydrogen/deuterium exchange it waspossibleto
distinguish N2-dimethylguanine (whichhasthreeexchangeable
positions) from ethylatedguanine isomers (whichhave fourex-
changeable positions) (32). A combination ofEIand fastatom
bombardment (FAB) daughter ion scanning on deuterium-
exchanged material confirmed thepresenceofN2-ethylguanine.
Evidencehasbeenobtainedtosuggestthattheconstituentofm/z
195 isN7-(2-hydroxyethyl)guanine (Fig. 3). Daughterionscans
ofm/z 195 onurinefractionselutedwith70% aqueousmethanol
from a Sep-Pak column yielded ions consistent with this struc-
ture (Fig. 4).
Furtherinvestigationofurinaryalkylpurines wascarriedout
using GC-MS and GC-MS-MS. Samples were partially
purified by Sep-Pakchromatography and in somecasesHPLC,
and converted to their TBDMS derivatives. The presence of
N7-methyl-, N2-methyl-, N2-dimethyl-, N2-ethyl- and N7-
(2-hydroxyethyl)-guanine in urine was confirmed by GC-MS
SIR. Deuterated analogs ofthese fivealkylguanines were syn-
thesizedandarebeingusedasinternalstandards forquantitation
byGC-MS using SIRorGC-MS-MS using MRM. FAB MS-
MS has also been used (on underivatized samples) as further
structure confirmation.
N7-(2-hydroxyethyl)guanine could just be detected by SIR
(maximum levels 3 ig/24hr)butnotbythelesssensitivetechni-
que ofMRM. Its presence is ofinterest as it is unlikely to be a
tRNA component and probably represents exogenous or en-
dogenousexposuretoahydroxyethylating agent. N2-Methyland
N2-dimethylguanine arebothderivedfromtRNA, butthe source
ofN2-ethylguanine is unknown.
Urinary Thymine Glycol
AfurthertypeofdamagethatoccursinDNAiscausedbyac-
tiveoxygenspecies. Hydroxyl radicalsproducemodificationof
allfourDNAbasesandmeasurementoftheextentofformationof
thesemaybeusedasanindicationofexposure. Oneexample, cis-
thymineglycol(TG) (Fig. 3),hasbeendetectedinurinebyHPLC
(33). WehavenowdevelopedaGC-MSassayforTG,inwhichit
isquantitatedusingad3-labeledinternalstandard. Theprocedure
involvescharcoalextraction(toremovecontaminants),chromato-
graphyonaboronateaffinitycolumn,andconversionofTGtoits
TBDMSderivative. Satisfactorycalibrationlinessuitableforthe
detectionof1 ngTG/mLurinehavebeengenerated. Arepresen-
tative SIR trace is shown in Figure 5. Preliminary values for
background levels in urine are0-750pg/mL.
Conclusion
This review has dealt only with MS methods for detecting
background adducts and has concentrated on those formed by
lowmolecularweightalkylating agents. Itshouldbepointed out
thatMSevidencealsoexists forthepresenceofbenzo[a]pyrene
adducts inplacental DNAfromnonsmokers (34), andthereare
many studieswherebenzo[a]pyreneadductshavebeendetected
byothertechniques both inDNA(35)andinserumprotein(36).
Atpresentit is impossible todraw firm conclusions as to the
source ofmost background adducts. However, the presence of
benzo[a]pyrene or aromatic amine adducts would clearly in-
dicate exogenous exposure to the chemicals. For the lower
molecular weightadducts, bothexogenous andendogenousex-
posurearelikelytobeinvolved, hydroxyethylationbeingofpar-
ticularinterestowingtoitspresenceinbothHbandnucleicacids.
Formethylatedadducts, theirendogenousgenerationordietary
uptake is so high that it is notpossible to determine exogenous
sources ofmethylating agentexposure, except underspecial cir-
cumstances suchasdietarycontrol (30). However, exceptinthe
caseswherebackgroundadductsareincorporated intactfroman
exogenous source (e.g., diet), their presence must indicate a
background carcinogen risk, against which the relative risk
associated withenvironmental exposuretocarcinogens mustbe
assessed.
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